Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
$3.5M annual revenue 2025; $86.1M total funding (Series C Oct 2023); deployed in 60+ countries; acquired Regen adding 130K acres; 134 employees; precision agriculture market $8.7B 2024; subscription-based model
CropX is a precision agriculture company that provides cloud-based soil sensing and irrigation management solutions to help farmers optimize water usage and maximize crop yields. The company serves commercial farmers, agronomists, and agricultural enterprises seeking data-driven irrigation decisions and improved resource efficiency. CropX delivers value through its wireless soil sensors that monitor moisture, temperature, and electrical conductivity in real-time, adaptive irrigation algorithms that recommend precise watering schedules, and analytics that reduce water consumption while maintaining or improving crop productivity.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.